Application of vascular ports at patients treated with chemotherapy
Keywords:
vascular port, chemotherapy, extravasation of drugAbstract
Treatment with chemotherapy is related to local reactions as results of accidental extravasation of drug. It is estimated that about 0,45-6,4 percent of patients suffer from extravasation of cytostatic drugs to perivascular space during chemotherapy. In case of the patients who are going to take chemotherapy, especially long term chemotherapy, it is suggested implantation of vascular port in order to give cytostatic drugs, infusions, whole blood or blood products. The mentioned system prevents local side-effects of extravasation of drugs. Vascular port guarantees permanent intravenous access. It is necessary to use in treatment of colorectal cancer, breast cancer and lymphoma. It is also used in treatment of the patients with some chronic disease, with being in terminal care and children with haemophilia. Contradictions to implantation are the same as in case of each vascular access system and they include coagulation disorders, infections and dermatosis in the place of planned operation. After implanting of the port, there might appear complications such as pneumothorax, blood-vessel perforation or heamatoma in the place of implantation of the port. Late complications comprise thrombosis and local or general infections. Occasionally dermatonecrosis, catheter migration and occlusion appear. The patients with the port should limit physical activity involving arms and schoulder girdle. They schould not press the place near the catheter, so as not to disturb the work of the port. When catheter is not used for four weeks, it is required to fill it with heparin solution. Vascular ports at patients treated with chemotherapy improve their quality of life.
Downloads
References
Karczmarek-Borowska B., Matczuk M.: Postępowanie przy wynaczynieniu leków stosowanych w leczeniu nowotworów, Współczesna Onkologia 2004, 1: 29–32.
Łuszczyk M., Łuszczyk R., Jerzak P.:, Port naczyniowyzastosowanie i pielęgnacja. http://www.raabe.com.pl/pdf/medycyna/artykul-pielegniarki.pdf.
Dworzański K.: Pacjent z portem naczyniowym w trakcie radioterapii, Medipress Medical Update Supp. 2004, 5: 13.
Vescia S., Baumgartner A. K., Jacobs V. R., KiechleBahat M., Rody A.: Postępowanie z portami żylnymi w onkologii – przegląd bieżących badań, Medycyna Praktyczna – Onkologia 2008; 5: 11–20.
Jarosz J., Krzakowski M., Dworzański K., Czech I., Filipczyk-Cisarz E., Głogowska I.: Wszczepialne systemy dostępu naczyniowego o długotrwałym zastosowaniu, Onkologia w Praktyce Klinicznej 2006; 1: 40–48.
Goździk J.: Porty naczyniowe – zastosowanie kliniczne, Przewodnik Lekarza 2007; 1: 98–103.
Pawłowicz M., Dworzański K.: Wszczepialne porty naczyniowe w leczeniu choroby nowotworowej, Medipress Medical Update Supp. 2004, 5: 3–10.
Młynarski R.: Zastosowanie portów dożylnych w opiece paliatywnej, http://www.czytelniamedyczna.pl/nm_op07.php
Piotrowska W., Łuczak J., Kowalski G., Kotlińska-Lemieszek A.: Dojście dożylne typu „port” w opiece paliatywnej– zastosowanie, powikłania, Onkol. Pol. 2008; 11(4): 138–140.
Yldizeli B., Lacin T., Batirel HF., Yuksel M.: Complications and management of longterm central venous access catheters and ports, J. Vasc. Access 2004; 5(4): 174–178.
Craus W., Di Giacomo A., Tommasino U., Frezza A., Festa G., Cricri AM.: Totally Implantable Central Venous Access: 15 years' experience in a single unit. J. Vasc, Access 2001; 2(4): 161–167.
Yeste Sanchez L., Galbis Caravajal JM., Fuster Diana CA., Moledo Eiras E.: Protocol for the implantation of a venous access device (Port-A-Cath System).The complications and solutions found in 560 cases. Clin Transl Oncol. 2006; 8(10): 735–741.
Florio G., Del Papa M., Mari A., Carni D.: Totally implantable central venous access devices in adult oncological patients, Chir Ital. 2008; 60(5): 697–702.
Dworzański K.: Zastosowanie portu w celu prowadzenia długoterminowego żywienia pozajelitowego, nawadniania i wyrównywania gospodarki elektrolitowej, Medipress Medical Update Supp. 2004, 5: 11–12
Pawłowicz M.: Powikłania w trakcie użytkowania portu naczyniowego związane z jego nieprawidłową obsługą, Medipress Medical Update Supp. 2004, 5: 15–16.
Nowakowska-Zajdel Z., Bucki B., Rusinowska Z., Żmuda-Siedlarczyk A., Muc-Wierzgoń M., Kokot T.: Długoterminowy dostęp żylny typu „port” u dorosłych pacjentów leczonych na Oddziale Onkologicznym – obserwacje własne, Wiadomości Lekarskie 2007; 11–12: 513–515.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2009 Medical Journal of the Rzeszow University
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
